Marine Products Corporation (MPX)

Marinus Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	14.04	17.85	41.7	40.35	29.03	19.44
Depreciation & Amortization	2.98	2.79	2.42	1.91	1.82	1.95
Loss (Gain) From Sale of Assets	-0.14	-0.14	-2.04	-	-	-0.03
Stock-Based Compensation	4.56	4.23	3.71	2.71	2.29	3.1
Other Operating Activities	-0.69	-1.14	-0.76	-0.62	-0.14	0.34
Change in Accounts Receivable	-0.33	-1.7	2.87	-2.08	1.44	1.9
Change in Inventory	1.9	11.65	11.4	0.25	-30.95	-0.76
Change in Accounts Payable	-0.82	-0.57	-2.18	1.48	0.69	2.19
Change in Income Taxes	0.08	-0.08	-0.33	-0.02	-0.01	0.91
Change in Other Net Operating Assets	-2.62	-3.36	0.07	5.38	-3.71	0.83
Operating Cash Flow	18.95	29.53	56.85	49.35	0.46	29.87
Operating Cash Flow Growth	-47.05%	-48.06%	15.19%	10698.25%	-98.47%	-11.92%
Capital Expenditures	-3.46	-4.6	-10.17	-2.5	-1.25	-2.1
Sale of Property, Plant & Equipment	0.16	0.16	2.3	-	-	0.03
Investing Cash Flow	-3.3	-4.43	-7.87	-2.5	-1.25	-2.07
Repurchase of Common Stock	-1.08	-0.93	-0.91	-0.7	-1.05	-2.49
Common Dividends Paid	-	-19.73	-19.28	-17.08	-15.63	-13.55
Other Financing Activities	4.46	-	-	-	-	-
Financing Cash Flow	-20.62	-44.67	-20.19	-17.78	-16.68	-16.04
Net Cash Flow	-4.96	-19.57	28.78	29.07	-17.47	11.77
Free Cash Flow	15.5	24.93	46.67	46.85	-0.79	27.78
Free Cash Flow Growth	-50.27%	-46.59%	-0.38%	-	-	-12.06%
Free Cash Flow Margin	6.91%	10.54%	12.16%	12.30%	-0.27%	11.58%
Free Cash Flow Per Share	0.45	0.72	1.35	1.37	-0.02	0.82
Cash Income Tax Paid	3.29	4.48	13.91	13.02	7.49	4.1
Levered Free Cash Flow	14.41	19.78	40.42	37.18	-8.04	24.96
Unlevered Free Cash Flow	14.42	19.78	40.42	37.18	-8.04	24.96
Change in Net Working Capital	-1.25	-6.03	-13.49	-2.7	33.64	-6.78

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q